89
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment

, , , , , , , & show all
Pages 253-257 | Published online: 21 May 2014

References

  • BrarNKNiedermanMSManagement of community-acquired pneumonia: a review and updateTher Adv Respir Dis20115617820935033
  • FineMJSmithMACarsonCAPrognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA19962751341418531309
  • MandellLAWunderinkRGAnzuetoAInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adultsClin Infect Dis200744S2S27
  • KohnoSSekiMWatanabeAEvaluation of an assessment system for the JRS 2005: A-DROP for the management of CAP in adultsIntern Med2011501183119121628933
  • KaralusNCCursonsRTLengRACommunity acquired pneumonia: aetiology and prognostic index evaluationThorax1991464134181907034
  • NeillAMMartinIRWeirRCommunity acquired pneumonia: aetiology and usefulness of severity criteria on admissionThorax199651101010168977602
  • LiebermanDSchlaefferFBoldurIMultiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patientsThorax1996511791848711652
  • Van BambekeFReinertRRAppelbaumPCTulkensPMPeetermansWEMultidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic optionsDrugs2007672355238217983256
  • ClarkCLKosowska-ShickKEdnieLMAppelbaumPCCapability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologiesAntimicrob Agents Chemother2007514196420117876003
  • BrandonMDowzickyMJAntimicrobial susceptibility among Gram-positive organisms collected from pediatric patients globally between 2004 and 2011: results from the Tigecycline Evaluation and Surveillance TrialJ Clin Microbiol2013512371237823678070
  • Japan Nosocomial Infections Surveillance[Data from Jul to Sep 2013] Available from: http://www.nih-janis.jp/report/open_report/2013/2/1/ken_Open_Report_201303.pdfAccessed April 21, 2014 Japanese
  • Infectious Diseases Society of AmericaPenicillin’s back: FDA raises breakpoints for S. pneumoniae pneumonia412008 Available from: http://news.idsociety.org/idsa/issues/2008-04-01/11.htmlAccessed April 21, 2014
  • RocaABottomleyCHillPCEffect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriageClin Infect Dis20125581682422700830
  • DavisSMDeloria-KnollMKassaHTO’BrienKLImpact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effectsVaccine20133213314523684824
  • AnsaldiFde FlorentiisDCanepaPCarriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementationHum Vaccin Immunother201393
  • HsuKKSheaKMStevensonAEPeltonSIMassachusetts Department of Public Health 2010Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001–2007Pediatr Infect Dis201029289293
  • KyawMHLynfieldRSchaffnerWEffect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniaeN Engl J Med20063541455146316598044
  • MaruyamaTTaguchiONiedermanMSEfficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trialBMJ2010340c100420211953
  • MoberleySHoldenJTathamDPAndrewsRMVaccines for preventing pneumococcal infection in adultsCochrane Database Syst Rev20131CD00042223440780